Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Date Time Source Announcement
21 May 2018 11:02 am
RNS
ViiV granted EU marketing authorisation for Juluca
15 May 2018 1:39 pm
RNS
Director/PDMR Shareholding
11 May 2018 3:17 pm
RNS
Director/PDMR Shareholding
10 May 2018 5:20 pm
RNS
Block listing Interim Review
09 May 2018 5:05 pm
RNS
Director/PDMR Shareholding - replacement
  12:00 pm
RNS
Directorate Change
03 May 2018 6:31 pm
RNS
Result of General Meeting
  6:29 pm
RNS
Result of AGM
01 May 2018 2:45 pm
RNS
Total Voting Rights
27 Apr 2018 12:43 pm
RNS
Director/PDMR Shareholding
26 Apr 2018 3:30 pm
RNS
Director/PDMR Shareholding
25 Apr 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
1st Quarter Results
24 Apr 2018 5:41 pm
RNS
Trelegy Ellipta expanded US COPD indication
20 Apr 2018 3:15 pm
RNS
Director/PDMR Shareholding
  3:15 pm
RNS
Director/PDMR Shareholding
19 Apr 2018 7:00 am
RNS
IMPACT study shows benefits of Trelegy Ellipta
18 Apr 2018 10:34 am
RNS
Landmark IMPACT study to be published in NEJM
17 Apr 2018 1:47 pm
RNS
Director/PDMR Shareholding
  1:36 pm
RNS
Director/PDMR Shareholding
  1:30 pm
RNS
Director/PDMR Shareholding
  1:24 pm
RNS
Director/PDMR Shareholding
  1:20 pm
RNS
Director/PDMR Shareholding
13 Apr 2018 3:50 pm
RNS
Director/PDMR Shareholding
  3:44 pm
RNS
Director/PDMR Shareholding
  11:32 am
RNS
Notice of GM
12 Apr 2018 3:04 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 4:14 pm
RNS
Total Voting Rights
29 Mar 2018 1:00 pm
RNS
Notice of AGM
27 Mar 2018 7:00 am
RNS
GSK agrees to acquire CH business from Novartis
23 Mar 2018 11:21 am
RNS
ViiV - CHMP positive opinion for Juluca in Europe
  7:44 am
RNS
Update regarding Pfizer Inc. Consumer Healthcare
  7:00 am
RNS
Shingrix approved in Europe and Japan
19 Mar 2018 7:00 am
RNS
GSK 2017 Form 20-F
13 Mar 2018 2:10 pm
RNS
Annual Financial Report
12 Mar 2018 4:30 pm
RNS
Director/PDMR Shareholding
08 Mar 2018 8:00 am
RNS
GSK announces labelling update to Relvar Ellipta
05 Mar 2018 5:01 pm
RNS
ViiV Healthcare announces new dolutegravir data
  2:47 pm
RNS
Nucala OSMO study presented at AAAAI-WAO congress
  12:04 pm
RNS
Director/PDMR Shareholding
02 Mar 2018 1:11 pm
RNS
Director/PDMR Shareholding
01 Mar 2018 11:16 am
RNS
Total Voting Rights
22 Feb 2018 4:54 pm
RNS
Director/PDMR Shareholding
20 Feb 2018 1:17 pm
RNS
Director/PDMR Shareholding
  1:16 pm
RNS
Director/PDMR Shareholding
  1:15 pm
RNS
Director/PDMR Shareholding
19 Feb 2018 6:12 pm
RNS
Director/PDMR Shareholding
16 Feb 2018 5:29 pm
RNS
Director/PDMR Shareholding
  5:25 pm
RNS
Director/PDMR Shareholding
  11:20 am
RNS
Director/PDMR Shareholding
15 Feb 2018 6:09 pm
RNS
Director/PDMR Shareholding
  5:57 pm
RNS
Director/PDMR Shareholding
  5:53 pm
RNS
Director/PDMR Shareholding
14 Feb 2018 9:00 am
RNS
GSK submits landmark IMPACT data - Trelegy Ellipta
13 Feb 2018 4:44 pm
RNS
Director/PDMR Shareholding
12 Feb 2018 2:43 pm
RNS
Director/PDMR Shareholding
  12:47 pm
RNS
Director/PDMR Shareholding
08 Feb 2018 9:31 am
RNS
ViiV Healthcare launches new two-drug HIV study
  7:00 am
RNS
ViiV files patent infringement litigation
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t